If you need an accessible version of this item please contact JSTOR User Support

Restricted Randomization Designs in Clinical Trials

Richard Simon
Biometrics
Vol. 35, No. 2 (Jun., 1979), pp. 503-512
DOI: 10.2307/2530354
Stable URL: http://www.jstor.org/stable/2530354
Page Count: 10
  • Download PDF
  • Cite this Item

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If you need an accessible version of this item please contact JSTOR User Support
Restricted Randomization Designs in Clinical Trials
Preview not available

Abstract

Though therapeutic clinical trials are often categorized as using either "randomization" or "historical controls" as a basis for treatment evaluation, pure random assignment of treatments is rarely employed. Instead various restricted randomization designs are used. The restrictions include the balancing of treatment assignments over time and the stratification of the assignment with regard to covariates that may affect response. Restricted randomization designs for clinical trials differ from those of other experimental areas because patients arrive sequentially and a balanced design cannot be ensured. The major restricted randomization designs and arguments concerning the proper role of stratification are reviewed here. The effect of randomization restrictions on the validity of significance tests is discussed.

Page Thumbnails

  • Thumbnail: Page 
503
    503
  • Thumbnail: Page 
504
    504
  • Thumbnail: Page 
505
    505
  • Thumbnail: Page 
506
    506
  • Thumbnail: Page 
507
    507
  • Thumbnail: Page 
508
    508
  • Thumbnail: Page 
509
    509
  • Thumbnail: Page 
510
    510
  • Thumbnail: Page 
511
    511
  • Thumbnail: Page 
512
    512